Drug or technology
6 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
Recruitment-completed interventional trial with behavioural diet interventions in Alzheimer's disease, but no results are reported in this registry record, preventing assessment of efficacy or safety.
SEP 4, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a clinical trial registration with no results posted; it describes a planned interventional study in an early recruitment phase testing nicotinamide riboside and ketogenic diet on metabolic outcomes in overweight/obese adults and those with MODY2 diabetes.
This is a completed interventional study with 120 participants and defined metabolic endpoints, but the registry record contains no results, only study design and planned outcomes.
This is a recruiting interventional study with no posted results; it represents early-phase work designed to assess feasibility and correlates rather than establish efficacy.
AUG 11, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
Early-phase, single-centre Phase 2 interventional study with small planned enrollment (n=15) examining a surrogate endpoint (hyperglycemia-free rate) in an exploratory design; results not yet reported in this registry record.
AUG 7, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a planned interventional trial with no results reported; it addresses a novel combination (ketogenic diet + iTBS for TRD) in a small estimated sample, making it preliminary in nature pending enrollment and outcome reporting.